Shock and kill (original) (raw)

• News & Views
• Published: 25 July 2012

HIV

Nature volume 487, pages 439–440 (2012)Cite this article

• 13k Accesses
• 574 Citations
• 24 Altmetric
• Metrics details

Subjects

Antiretroviral therapies block HIV replication but they do not eliminate inactive viruses within cells. A clinical trial shows that a drug can revive HIV in patients as a potential first step towards a cure. See Letter p.482

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Figure 1: Getting HIV out of its hiding place.

The alternative text for this image may have been generated using AI.

References

1. Richman, D. D. et al. Science 323, 1304–1307 (2009).
   Article ADS CAS Google Scholar
2. Trono, D. et al. Science 329, 174–180 (2010).
   Article ADS CAS Google Scholar
3. Archin, N. M. et al. Nature 487, 482–485 (2012).
   Article ADS CAS Google Scholar
4. Siliciano, J. D. et al. Nature Med. 9, 727–728 (2003).
   Article CAS Google Scholar
5. Archin, N. M. et al. AIDS Res. Hum. Retroviruses 25, 207–212 (2009).
   Article CAS Google Scholar
6. Contreras, X. et al. J. Biol. Chem. 284, 6782–6789 (2009).
   Article CAS Google Scholar
7. Blazkova, J. et al. J. Infect. Dis. http://dx.doi.org/10.1093/infdis/jis412 (2012).
8. Shan, L. et al. Immunity 36, 491–501 (2012).
   Article CAS Google Scholar
9. Hansen, S. G. et al. Nature 473, 523–527 (2011).
   Article ADS CAS Google Scholar
10. Persaud, D. et al. AIDS 25, 2227–2234 (2011).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

1. Steven G. Deeks is in the Department of Medicine, University of California, San Francisco, San Francisco, California 94110, USA.,
   Steven G. Deeks

Corresponding author

Correspondence toSteven G. Deeks.

Ethics declarations

Competing interests

The author has received grant support from Merck, a pharmaceutical company that produces the drug vorinostat.

Rights and permissions

About this article

Cite this article

Deeks, S. Shock and kill.Nature 487, 439–440 (2012). https://doi.org/10.1038/487439a

Download citation

• Published: 25 July 2012
• Issue date: 26 July 2012
• DOI: https://doi.org/10.1038/487439a

This article is cited by